Target intelligence / Profile preview

Insulin receptor β-subunit (IR β-subunit)

Target
IR β-subunit
Molecular classification
Receptor, Enzyme, Receptor tyrosine kinase
01

Overview

The insulin receptor β-subunit is the transmembrane and intracellular portion of the insulin receptor, a prototypical receptor tyrosine kinase that mediates insulin signaling in target cells[6][7][9][10]. The β-subunit is essential for signal transduction, containing the tyrosine kinase domain that becomes activated upon insulin binding to the extracellular alpha subunit[6][7][8][9][10]. The insulin receptor is a heterotetrameric protein comprising two alpha (α) subunits and two beta (β) subunits. The α-subunit is entirely extracellular and responsible for insulin binding, while the β-subunit spans the membrane and contains both transmembrane and intracellular portions[7][9][10]. The intracellular segment of the β-subunit harbors the receptor’s tyrosine kinase activity, critical for propagating insulin’s effects[6][7][10]. Upon insulin binding to the α-subunit, the β-subunit undergoes autophosphorylation, initiating downstream signaling cascades such as glucose uptake, glycogen synthesis, and inhibition of glucose production[6][7][8].

Other names
INSR β-subunitInsulin receptor beta chainβIRInsulin receptor kinase subunit
02

Mechanism of action

Activation/agonism: Insulin or agonists bind the extracellular α-subunit, triggering autophosphorylation of the β-subunit’s cytoplasmic kinase domain and downstream signaling. Tyrosine kinase inhibition: Experimental approaches in research settings

03

Biological functions

Signal transductionRegulation of glucose metabolismCell growth and differentiationGene expression modulationCell proliferation
04

Disease associations

Diabetes mellitusCancerMetabolic syndromeCardiovascular diseaseInsulin receptoropathy syndromes
05

Safety considerations

Downregulation and resistance: Chronic excessive activation (e.g., hyperinsulinemia) leads to insulin resistance in target tissuesMitogenic risk: Overstimulation in certain cells may promote unwanted proliferation, possibly conferring cancer riskHypoglycemia: Over-activation or exogenous insulin excess can lower blood glucose dangerouslyAutoimmunity: Rarely, immune reactions against the receptor
06

Interacting drugs

Insulin (various analogs)

2 more in the full profile.

07

Biomarkers

Phosphorylation status of β-subunit (especially tyrosine phosphorylation)Insulin receptor signaling intermediates (e.g., IRS protein phosphorylation)Cell-surface receptor density or expression levels

Beyond the preview

Go deeper on Insulin receptor β-subunit (IR β-subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin receptor β-subunit (IR β-subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call